New Delhi: India launched the world’s biggest vaccination drive with two ‘Made in India vaccines- Covishield and Covaxin- against the coronavirus disease which has claimed more than 1 lakh 50 thousand people in the country. Covishield is made by Serum Institute of India (SII) and Covaxin is manufactured by Bharat Biotech.
Three days after India kick-started mass inoculation against COVID-19 Biotech has come out with a fact sheet about the process involved and who should avoid taking the vaccine.
According to the fact sheet posted on Bharat Biotech’s website, it is advisable not to take the vaccine if a person has allergies, fever or bleeding disorder, weaker immunity or are on a medicine that affects their immune system.
It also said that pregnant and breastfeeding women should also avoid taking Covaxin. Those who have received another COVID-19 should also not get the Bharat Biotech’s medicine, the company said.
The factsheet lists side effects that include pain, swelling or itching, fever, malaise, weakness, rashes, nausea and vomiting. Recipients are also warned of severe allergic reaction that may include difficulty in breathing, swelling of the face and throat, fast heart-beat, rashes all over the body, dizziness and weakness.
Earlier, the govt had said that someone who had an adverse reaction to a previous COVID vaccine dose or allergic to any other vaccine, pregnant women and lactating mothers should not take Covid jabs.
So who all are eligible to get Covaxin shots?
The fact sheet from Bharat Biotech says that CDSCO has authorised the restricted use of its vaccine under clinical trial mode.
“Individuals who are prioritised under the public health program of the ministry of health and family welfare, will be covered under this endeavour. Informing the individuals about the offer for vaccination with Covaxin will rest with the respective government program officials. Those offered Covaxin at pre-specified booths will have the options to receive or reject administration of the vaccine,” the fact sheet said.
The company document further described the ingredients in the Covaxin. It contains 64g of whole-virion inactivated SARS-CoV-2 antigen (Strain: NIV-2020-770), and the other inactive ingredients such as aluminum hydroxide gel (250 μg), TLR 7/8 agonist (imidazoquinolinone) 15 μg, 2-phenoxyethanol 2.5 mg, and phosphate buffer saline up to 0.5 ml.
“The vaccine thus has been developed by using inactivated/killed virus along with the aforementioned chemicals,” said Bharat Biotech.